TechPrecision Corporation Reports Fiscal Year 2027 First Quarter Financial Results
TechPrecision Corporation (NASDAQ:TPCS) reported fiscal 2027 first-quarter results for the three months ended June 30, 2026. Revenue rose 23% to $9.1M and gross profit rose 36% to $1.4M. Net loss narrowed to $0.2M. Funded backlog was $52.7M, plus $22M unfunded orders. FY2027 guidance: revenue +10% to $35.0M-$37.0M and EBITDA +80% to $3.0M-$4.0M.
How this was made
The 30-second read
Why it matters
The quarter shows higher revenue and gross profit, improved net loss, and reiterated FY2027 guidance, supported by a sizable funded backlog. However, the balance sheet remains tight with very low cash and negative working capital attributed to debt covenant violations.
Market read
Traders can reassess near-term expectations for revenue growth, gross margin improvement, and EBITDA trajectory based on the reported quarter and backlog, while monitoring covenant and liquidity risk.
What to watch
The article highlights funded backlog and unfunded purchase orders, but does not quantify gross margin rates, cash flow, or the specific drivers of interest expense changes, which could be key to validating the EBITDA growth outlook.
Background
TechPrecision is a custom manufacturer serving defense and precision industrial markets through two segments, Ranor and Stadco.
Ticker impact
TechPrecision reported FY2027 Q1 revenue of $9.1M (+23%) and gross profit of $1.4M (+36%), plus FY2027 guidance and backlog figures.
Near-term bias modestly positive on earnings-day positioning, with follow-through dependent on whether investors focus on margin trajectory and backlog conversion versus balance-sheet risk.
The article provides concrete quarterly P&L changes (revenue, gross profit, net loss improvement) and reiterates FY2027 guidance, while also disclosing negative working capital and covenant-related current-debt classification that can cap upside sentiment.
Market effects
Defense and precision manufacturing suppliers may see read-through interest if backlog and margin improvement appear durable, but this is company-specific.
Limited, as operations are in Massachusetts and Los Angeles with no broader regional macro signal.
Low, as the disclosure is not tied to global demand shocks or international regulatory actions.
Counterpoint
Investors may discount the revenue and gross profit growth if backlog conversion and gross margin improvement are not evidenced by cash generation, given negative working capital and covenant-related current debt classification.
Key entities
- companyTechPrecision Corporation
NASDAQ-listed custom precision manufacturer reporting FY2027 Q1 results and reiterating guidance.
- segmentRanor
Defense-centric segment with revenue and gross profit growth driven by customer and project mix.
- segmentStadco
Defense-centric segment where losses narrowed and revenue rose on a strategic project mix change.
- executiveAlexander Shen
CEO who discussed segment performance, backlog, and FY2027 guidance.
